Multidrug-Resistant Tuberculosis (MDR-TB) and Novel Therapies

This track focuses on the growing challenge of multidrug-resistant tuberculosis (MDR-TB) and the development of novel therapies. Experts will discuss the mechanisms of drug resistance, challenges in treatment adherence, and innovative therapeutic approaches, including new drug combinations and shorter treatment regimens. Attendees will gain valuable insights into global initiatives aimed at controlling MDR-TB and ensuring equitable access to effective treatment.

    Related Conference of Multidrug-Resistant Tuberculosis (MDR-TB) and Novel Therapies

    February 25-26, 2027

    3rd World Congress on Pathology and Laboratory Medicine

    Paris, France
    April 23-24, 2027

    15th Annual Congress on Pulmonary and Critical Care

    Paris, France

    Multidrug-Resistant Tuberculosis (MDR-TB) and Novel Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in